Products

What will AGI do for Batanopride?

This classification denotes an antiemetic agent with the molecular formula C17H26ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1AT99K728N, chemically known as benzamide, 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-(1-methyl-2-oxopropoxy)- but generally known as batanopride, which bears US NIH Compound Identifier 59692. Batanopride most often comes in base and hydrochloride forms. European Medicines Agency schedules Batanopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06108MIG. The term BATANOPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). BATANOPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule batanopride under HS 29242995 and SITC 51479. As of Q4 2014, BATANOPRIDE remains the US FDA Preferred Term for this commodity. Batanopride bears US NLM identifiers UMLS ID C0053879 and NCI Concept Code C1021. SMILES: CLC1CC(C(=O)NCCN(CC)CC)C(OC(C)C(=O)C)CC1N.